IRMD

Q: What is the price of iRadimed (IRMD) today?

The price of iRadimed (IRMD) today is $ 93.22, with return of 75.84% compared to the last year. The price of iRadimed (IRMD) started the year trading around $ 55.00 and today it is at $ 93.22. Follow the real-time price chart, the historical price of iRadimed (IRMD) and international markets.

Q: When does iRadimed (IRMD) pay dividends?

iRadimed (IRMD) distributed dividends in the last year,in the months of March, May, August and November totaling $ 0.68. The Dividend Yield for the last 12 months is 0.74%.

Q: Is iRadimed (IRMD) worth it?

Currently, iRadimed (IRMD) is priced at $ 93.22, with a P/E of 54.92%, representando um desvio de 4,222% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 75.84 in its price and distributed $ 0.68 in dividends, resulting in a Dividend Yield of 0.74%. The total shareholder return was 75.84%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy iRadimed (IRMD) stock?

Investing in stocks of iRadimed (IRMD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of iRadimed (IRMD) yield today?

The yield of iRadimed (IRMD) was 19.28% in the last month, 75.84% in the last year and 310.26% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.68 in dividends, a Dividend Yield of 0.74%.If you wanted to buy 100 stocks of iRadimed (IRMD) today, the total investment would be $ 9,322.00, based on the current price of $ 93.22.If past performance were to repeat, the return on your investment would be:In 1 year: $ 16,391.80In 5 years: $ 38,244.44In 10 years: $ 29,852.77It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

iRadimed Corporation

Price

$ 93.22

return (12m)

75.84%

p/e

54.92

p/bv

11.83

DIVIDEND YIELD

0.74%

price IRMD

IRMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of IRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.28%

3 months

28.95%

1 year

75.84%

2 years

127.80%

5 years

310.26%

10 years

220.24%

Fundamentals IRMD

review the fundamentals of iRadimed shares

P/E

54.92

Sector: -2.16 Industry: -0.67

P/SALES RATIO (PSR)

14.45

Sector: 1.99 Industry: 2.51

P/BV

11.83

Sector: 2.12 Industry: 2.30

DIVIDEND YIELD (DY)

0.74%

Sector: - Industry: -

ROA

18.47%

Sector: -26.99% Industry: -25.01%

ROE

21.55%

Sector: -30.03% Industry: -30.75%

ROIC

43.21%

Sector: -414.93% Industry: -73.73%

NET MARGIN

26.32%

Sector: -27.97% Industry: -29.36%

GROSS MARGIN

77.07%

Sector: 44.10% Industry: 50.75%

OPERATING MARGIN

30.87%

Sector: -24.33% Industry: -25.70%

P/EBITDA

45.37

Sector: -0.32 Industry: 1.47

P/EBIT

46.83

Sector: -2.46 Industry: -1.00

P/ASSET

10.14

Sector: 1.19 Industry: 1.27

BVPS

7.57

Sector: 3.38 Industry: 4.47

EPS

1.63

Sector: -0.89 Industry: -0.87

EQUITY RATIO

0.86

Sector: 0.43 Industry: 0.45

CAGR REVENUE 5 YEARS

20.48%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

72.96%

Sector: - Industry: -

FAIR VALUE OF iRadimed ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 93.22

Fair Value

$ 0.00

Upside Return potential.

-82.13%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IRMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	51.55	39.80	77.20%	0.55%	$ 949.16 B	30.99%
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
NVS	17.04	5.48	32.16%	3.04%	$ 245.20 B	25.53%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
GSK	12.93	4.43	34.29%	3.52%	$ 94.37 B	17.23%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IRMD Historical Dividends

current DY: 0.74%

5-year average DY: 2.36%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	11/14/2025	11/25/2025	0,17000000
Dividend	08/18/2025	08/28/2025	0,17000000
Dividend	05/20/2025	05/30/2025	0,17000000
Dividend	02/24/2025	03/05/2025	0,17000000
Dividend	11/15/2024	11/25/2024	0,15000000
Dividend	08/20/2024	08/30/2024	0,15000000
Dividend	05/20/2024	05/30/2024	0,15000000
Dividend	12/22/2023	01/12/2024	0,15000000
Dividend	02/13/2023	02/21/2023	1,05000000
Dividend	02/17/2022	02/24/2022	1,00000000

ABOUT THE COMPANY iRadimed

iRadimed Corporation

Average user rating I10

4.0 (6 people)

United States

33 years

Founded: 1992

2014

Time since IPO - 11 years

110

Employees

The Company iRadimed Corporation (United States), is listed on Nasdaq with a market cap of $ 1.16 Billion, having an equity of $ 98.35 Millions.

With a total of 110 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 80.51 Millions, which generated a profit in the amount of $ 21.19 Millions.

As for its main indicators, the Company has a P/E ratio of 54.92, a P/BV ratio of 11.83 and in the last 12 months the dividend yield of IRMD was at 0.74%.

The Company is traded internationally through the ticker IRMD.

Market cap

$ 1.16 Billion

Equity

$ 98.35 Millions

US$ 98,350,000.00

Assets

$ 114.72 Millions

US$ 114,720,000.00

Total Shares Outstanding

13.00 Millions

13,000,000

Average Daily Trading Volume

$ 67.43 Thousand

US$ 67,430.48

Sector

Health

Industry

Medical Supplies and Equipment

IRMD

IRMD revenue and profits

Financial Results IRMD

DRAG THE FRAME TO SEE MORE DATA

IRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 80.36 40,01% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 277.28 --15,89% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 39.34 --34,43% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 245.77 --15,58% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 49.88 7,43% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 508.29 56,65% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

LLY - Eli Lilly

$ 1,075.47 35,70% (12M)

P/E

51.55

0.55%

ROE

77.20%

P/BV

39.80

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 80.36 40,01% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 277.28 --15,89% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 39.34 --34,43% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 245.77 --15,58% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 49.88 7,43% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 508.29 56,65% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

LLY - Eli Lilly

$ 1,075.47 35,70% (12 M)

P/L

51.55

0.55%

ROE

77.20%

P/VP

39.80

Frequently Asked Questions

What is the price of iRadimed (IRMD) today?

The price of iRadimed (IRMD) today is $ 93.22, with return of 75.84% compared to the last year. The price of iRadimed (IRMD) started the year trading around $ 55.00 and today it is at $ 93.22. Follow the real-time price chart, the historical price of iRadimed (IRMD) and international markets.

When does iRadimed (IRMD) pay dividends?

iRadimed (IRMD) distributed dividends in the last year,in the months of March, May, August and November totaling $ 0.68. The Dividend Yield for the last 12 months is 0.74%.

Is iRadimed (IRMD) worth it?

Currently, iRadimed (IRMD) is priced at $ 93.22, with a P/E of 54.92%, representando um desvio de 4,222% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 75.84 in its price and distributed $ 0.68 in dividends, resulting in a Dividend Yield of 0.74%. The total shareholder return was 75.84%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy iRadimed (IRMD) stock?

Investing in stocks of iRadimed (IRMD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of iRadimed (IRMD) yield today?

The yield of iRadimed (IRMD) was 19.28% in the last month, 75.84% in the last year and 310.26% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.68 in dividends, a Dividend Yield of 0.74%.

If you wanted to buy 100 stocks of iRadimed (IRMD) today, the total investment would be $ 9,322.00, based on the current price of $ 93.22.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 16,391.80
In 5 years: $ 38,244.44
In 10 years: $ 29,852.77

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IRMD

iRadimed Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of IRMD

review the fundamentals of iRadimed shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.74%

5-year average DY: 2.36%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY iRadimed

iRadimed Corporation

United States

33 years

2014

110

PROFIT X PRICE IRMD

Financial Results IRMD

IRMD cash flow

asset growth - IRMD

IRMD balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions